Answers are grounded in this paper and cite their sources.
Evaluation of preoperative CA19-9 and NLR predicts early recurrence in patients with pancreatic ductal adenocarcinoma, implying potential for improved outcomes.
Objectives Pancreatic ductal adenocarcinoma (PDAC) has a high recurrence rate post-curative surgery. This study aimed to evaluate the combined predictive value of preoperative carbohydrate antigen 19-9 (CA19-9) and neutrophil-to-lymphocyte ratio (NLR) for early recurrence in resected PDAC patients.
No takes yet. Share an insight, caveat, or question.
Ye et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: